The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis.

depression fatigue longitudinal multiple sclerosis quality of life

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
05 Jun 2021
Historique:
received: 10 05 2021
accepted: 01 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

The interrelations between fatigue, depression and health-related quality of life (HRQoL) in persons with multiple sclerosis (PwMS) are complex, and the directionality of the effects is unclear. To address this gap, the current study used a longitudinal design to assess direct and indirect effects of fatigue and depression on HRQoL in a one-year follow-up survey. A sample of 210 PwMS from the nationwide Swiss MS Registry was used. HRQoL was assessed using the European Quality of Life 5-Dimension 5-Level questionnaire. Path analysis on HRQoL, with fatigue and depression as predictors, was applied. Fatigue was measured by the Modified Fatigue Impact Scale (MFIS), including physical, cognitive and psychosocial subscales, and non-somatic depressive symptomatology was examined with the Beck Depression Inventory-Fast Screen (BDI-FS). Fatigue acted as a fully mediating variable (B = -0.718, SE = 0.253) between non-somatic depressive symptomatology and HRQoL. This indirect effect became apparent in the physical (B = -0.624, SE = 0.250), psychosocial (B = -0.538, SE = 0.256) and cognitive subscales (B = -0.485, SE = 0.192) of fatigue. In contrast, non-somatic depressive symptomatology did not act as a mediator. Our findings provide novel and clinically relevant longitudinal evidence showing that the debilitating effect of non-somatic aspects of depression on HRQoL was fully mediated and therefore explainable via fatigue.

Identifiants

pubmed: 34198920
pii: brainsci11060751
doi: 10.3390/brainsci11060751
pmc: PMC8227168
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Hartmann Müller-Stiftung für Medizinische Forschung
ID : not available
Organisme : Swiss Multiple Sclerosis Society
ID : not available

Références

Biomed Res Int. 2015;2015:519785
pubmed: 25861633
BMJ Open. 2018 Jan 23;8(1):e016297
pubmed: 29362245
Mult Scler Relat Disord. 2019 Nov;36:101368
pubmed: 31557681
J Neurol. 2009 Nov;256(11):1932-5
pubmed: 19629565
Mult Scler. 2003 Dec;9(6):616-20
pubmed: 14664476
Behav Res Methods. 2008 Aug;40(3):879-91
pubmed: 18697684
Mult Scler. 2000 Jun;6(3):181-5
pubmed: 10871830
Brain Behav. 2019 Dec;9(12):e01466
pubmed: 31709732
Clin Neuropsychol. 2016 Feb;30(2):201-15
pubmed: 26930374
Eur J Neurol. 2016 Sep;23(9):1482-6
pubmed: 27416110
Clin Infect Dis. 1994 Jan;18 Suppl 1:S79-83
pubmed: 8148458
Mult Scler Relat Disord. 2018 Oct;25:112-121
pubmed: 30059895
J Neurol Sci. 2014 Apr 15;339(1-2):57-63
pubmed: 24492009
Arch Neurol. 1992 Dec;49(12):1237-42
pubmed: 1449401
Swiss Med Wkly. 2018 May 16;148:w14623
pubmed: 29767828
Nat Rev Neurol. 2014 Sep;10(9):507-17
pubmed: 25112509
Arch Clin Neuropsychol. 2005 Jul;20(5):631-46
pubmed: 15894455
Psychosom Med. 2003 Jul-Aug;65(4):542-7
pubmed: 12883103
Mult Scler Relat Disord. 2020 Feb;38:101493
pubmed: 31835209
Value Health. 2010 Aug;13(5):631-5
pubmed: 20412541
Immunol Allergy Clin North Am. 2009 May;29(2):309-20
pubmed: 19389584
Arch Phys Med Rehabil. 2021 Apr 1;:
pubmed: 33812883
BMJ Open. 2020 Nov 30;10(11):e041249
pubmed: 33257490
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Mult Scler. 2003 Aug;9(4):397-403
pubmed: 12926846
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Neurol Sci. 2005 Apr 15;231(1-2):29-34
pubmed: 15792817
Mult Scler. 2005 Feb;11(1):76-80
pubmed: 15732270
Mult Scler. 2013 Feb;19(2):217-24
pubmed: 22729988
Br J Psychiatry. 2010 Jul;197(1):61-6
pubmed: 20592436
J Behav Med. 2015 Apr;38(2):237-50
pubmed: 24880636
Pharmacoeconomics. 2014 Jun;32(6):591-9
pubmed: 24671924
Eur J Neurol. 2012 Mar;19(3):431-7
pubmed: 21967324
J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):642-651
pubmed: 30683707
Mult Scler Relat Disord. 2020 Jul;42:102148
pubmed: 32371376
Neurology. 2010 Sep 28;75(13):1141-9
pubmed: 20876468
J Neurol. 2016 Jul;263(7):1418-26
pubmed: 27177997
Mult Scler. 2017 Aug;23(2_suppl):192-203
pubmed: 28643596
Mult Scler. 2003 Aug;9(4):393-6
pubmed: 12926845
BMC Neurol. 2018 Aug 13;18(1):111
pubmed: 30103695
J Psychosom Res. 1998 Jul;45(1):33-8
pubmed: 9720853
PLoS One. 2012;7(7):e41910
pubmed: 22860028
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Mult Scler. 2000 Apr;6(2):131-6
pubmed: 10773860
J Clin Exp Neuropsychol. 2015;37(7):722-32
pubmed: 26223270
Mult Scler. 2002 Dec;8(6):523-6
pubmed: 12474995
Multivariate Behav Res. 2004 Jan 1;39(1):99
pubmed: 20157642
Mult Scler Relat Disord. 2019 Feb;28:17-25
pubmed: 30530118
J Neurol Sci. 2002 Dec 15;205(1):51-8
pubmed: 12409184
Acta Neurol Scand. 2012 Mar;125(3):180-6
pubmed: 21615355
Neurology. 1996 Mar;46(3):628-32
pubmed: 8618657
Gen Hosp Psychiatry. 1999 Mar-Apr;21(2):106-11
pubmed: 10228890
Lancet Neurol. 2005 Oct;4(10):643-52
pubmed: 16168933
Rehabil Psychol. 2014 May;59(2):220-229
pubmed: 24661030
Neurology. 2016 Apr 12;86(15):1417-1424
pubmed: 26962068
Acta Neurol Scand. 2016 Sep;134 Suppl 200:47-54
pubmed: 27580906

Auteurs

Stephanie Rodgers (S)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich (UZH), 8001 Zurich, Switzerland.

Zina-Mary Manjaly (ZM)

Department of Neurology, Schulthess Clinic, 8008 Zürich, Switzerland.
Department of Health Sciences and Technology, Eidgenössische Technische Hochschule (ETH) Zurich, 8092 Zürich, Switzerland.

Pasquale Calabrese (P)

Division of Molecular and Cognitive Neuroscience, University of Basel, 4055 Basel, Switzerland.

Nina Steinemann (N)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich (UZH), 8001 Zurich, Switzerland.

Marco Kaufmann (M)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich (UZH), 8001 Zurich, Switzerland.

Anke Salmen (A)

Department of Neurology, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland.

Andrew Chan (A)

Department of Neurology, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland.

Jürg Kesselring (J)

Department of Neurology and Neurorehabilitation, Rehabilitation Centre Kliniken Valens, 7317 Valens, Switzerland.

Christian P Kamm (CP)

Department of Neurology, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland.
Neurology and Neurorehabilitation Center, Luzerner Kantonsspital, 6000 Lucerne, Switzerland.

Jens Kuhle (J)

Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital and University of Basel, 4031 Basel, Switzerland.

Chiara Zecca (C)

Department of Neurology, Multiple Sclerosis Center (MSC), Neurocenter of Southern Switzerland, 6900 Lugano, Switzerland.
Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), 6900 Lugano, Switzerland.

Claudio Gobbi (C)

Department of Neurology, Multiple Sclerosis Center (MSC), Neurocenter of Southern Switzerland, 6900 Lugano, Switzerland.
Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), 6900 Lugano, Switzerland.

Viktor von Wyl (V)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich (UZH), 8001 Zurich, Switzerland.

Vladeta Ajdacic-Gross (V)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich (UZH), 8001 Zurich, Switzerland.
Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich (PUK), 8032 Zurich, Switzerland.

Classifications MeSH